Search

everythinglearnresearchcommunity

for

Search:↓

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Cutaneous gene therapy could become a viable treatment for skin and hair disorders with improved vector development and gene expression control.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Human hair follicle stem cells help repair tendon injuries.

DM and AA may share a common cause.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

A woman with alopecia totalis regrew dark hair in bands after using a corticosteroid ointment.

Skin issues can indicate immune system problems.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Modified rat stem cells on a special scaffold improved blood vessel formation and wound healing in skin substitutes.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.